
Bharat Biotech had issued a statement saying, “Capacity expansion has been implemented across multiple facilities... to reach 700 million doses a year,” though it did not specify by when. The company did not respond to ET’s request for comment.
from Industry-Economic Times
Read The Rest:economictimes...